Search

everythinglearnresearchcommunity

for

Search:↓

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

The Scalp Coverage Scoring method reliably measures hair density from images.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

PRP shows promise for hair growth, but more research and standardized protocols are needed.

The position of the parietal whorl can predict safe donor areas for hair transplants in Korean men with male pattern baldness.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Xtressé™ gummies may help increase hair growth in women, especially in early hair loss stages.

The nanoemulsion with garlic oil, apple cider vinegar, and minoxidil could effectively treat alopecia areata.

Chemotherapy-induced hair loss may be linked to immune system changes, and certain treatments could help but need careful use.

New treatments are needed for non-scarring alopecia due to current limitations.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Trichoscan is a reliable method for measuring hair growth and monitoring treatment effectiveness in hair loss.

Pharmacists play a crucial role in personalized care and medication management.

Topical corticosteroid foams are effective, safe, and easy to use for treating various skin conditions.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Microneedling may help treat some autoimmune skin conditions, but more research is needed.

Hair-loss trials have increased, but need more diverse participants and standardized measures.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.